home / stock / antx / antx short
Short Information | AN2 Therapeutics Inc. (NYSE:ANTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 300 |
Total Actual Volume | 1,725,049 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 15 |
Average Short Percentage | 0.00% |
Is there a ANTX Short Squeeze or Breakout about to happen?
See the ANTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2018 | $55.00 | $57.61 | $57.71 | $53.8601 | 1,725,049 | 300 | 0.02% |
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 4.6% to $128.28 on volume of 215,349,874 shares Zoomcar Holdings Inc. (ZCAR) rose 34.0% to $0.183 on volume of 204,010,215 shares Maxeon Solar Technologies Ltd. (MAXN) fell 3.5% to $0.1736 on volume of 2...
Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determi...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...